Black Ridge Acquisition Corp. Switches Vote to an Extension
by Kristi Marvin on 2019-06-17 at 6:20pm

Black Ridge Acquisition Corp. (BRAC) filed a new preliminary proxy this morning, switching their previously scheduled shareholder vote to complete their combination with Allied Esports, to an extension vote.  In fact, BRAC had filed a definitive proxy for their combination vote as recently as last Wednesday, June 12th, with a vote date of June 28th. However, it looks like that timeline no longer works for this deal.

Here’s what we do know from today’s preliminary proxy, albeit, it’s not much:

  • The new vote date will take place in July, with an actual day to-be-determined.  However, BRAC runs out their clock July 10th, so presumably some date between July 1st and 10th.
  • The date BRAC is asking to extend to (new completion deadline) is left blank, so we still don’t know how many months BRAC will be asking for.
  • BRAC has included language for a monthly extension contribution, but the exact amount is currently left blank. The amount to be contributed will be on a “cents-per-share basis” and not as a flat amount, as seen recently in GigCapital1.
  • BRAC appears to be using an out-of-date conversion price for shareholders who opt to redeem.  BRAC states a “current conversion amount of approximately $10.29 per share”, based on $142,000,000 in trust.  However, the amount BRAC held in trust as of their most recent 10-Q (3/31/19) said the trust held $142,027,742. Huh? The trust can’t have lost $27,742 since March, and it’s earning interest, so that trust amount and $10.29 figure most likely just need to be updated.  (Per BRAC’s prospectus, they cannot removed interest from the trust for purposes other than taxes or $50,000 for liquidation expenses).
  • The record date will remain as June 10, 2019.

Lastly, Black Ridge announced their combination with Allied Esports and World Poker Tour back on December 19, 2018, six months ago.  Given that the current average for completed SPACs is currently 5.2 months from announcement to close, Black Ridge is overdue, plus, they’re about to ask for more time.  That’s a little worrisome.  Perhaps, now that this deal is close to a vote, BRAC has a little more insight into the amount of redemptions they might be facing.  The best way to protect against a run on the cash in trust is to backstop the transaction with a PIPE.  So maybe that’s in their future and the reason for the delay.

Stay tuned for any further updates.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved